Original Articles
Vol. 5 No. 1 (2026)
Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 22 January 2026
1386
Views
222
Downloads
Authors
Background: The prevalence of thrombophilia in patients with unprovoked thrombotic events varies across populations, justifying the need for region-specific data to guide appropriate testing strategies.
Methods: This study included patients aged 18-50 years presenting with unprovoked venous thrombosis (VT), arterial thrombosis (AT), or combined thrombotic events at an Indian tertiary care center between January 2018 and January 2022. Clinical characteristics and results of the thrombophilia evaluation were analyzed.
Results: A total of 226 patients were analyzed, of whom 160 (70.7%) had VT, 53 (23.4%) had AT, and 13 (5.7%) experienced combined thrombotic events. A positive thrombophilia work-up was observed in 33.2% of VT cases and 20.1% of AT cases. Antiphospholipid antibody syndrome (APS) was the most frequent abnormality detected, whereas inherited thrombophilia was less common. In VT patients, pulmonary involvement was significantly associated with positive thrombophilia results (p=0.04).
Conclusions: These findings support a selective approach to thrombophilia testing in patients with unprovoked VT, in line with current guideline recommendations, and highlight APS as the predominant thrombophilic abnormality in this population.
Downloads
Download data is not yet available.
Citations
1. Miceli G, Ciaccio AM, Tuttolomondo A. From circulating biomarkers to polymorphic variants: a narrative review of challenges in thrombophilia evaluation. J Clin Med 2025;14:3448. DOI: https://doi.org/10.3390/jcm14103448
2. Fazeli A, Shams M, Bahraini M, Abdelwahab M. Laboratory diagnosis of less common acquired and congenital thrombophilic risk factors. In: Dorgalaleh A, Samadov A, editors. Laboratory investigations of thrombophilia: clinical and practical aspects . Cham, Springer; 2025. p. 187–230. DOI: https://doi.org/10.1007/978-3-031-90986-3_13
3. Tomán E, Pintér JN, Hargitai R. The embodied experience of genetic inheritance in hereditary thrombophilia. Health (London) 2025;29:373–95. DOI: https://doi.org/10.1177/13634593241271011
4. Reich LM, Bower M, Key NS. Role of the geneticist in testing and counseling for inherited thrombophilia. Genet Med 2003;5:133–43. DOI: https://doi.org/10.1097/01.GIM.0000067987.77803.D0
5. Mateo J, Oliver A, Borrell M, et al. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost 1997;77:444–51. DOI: https://doi.org/10.1055/s-0038-1655986
6. Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematology Am Soc Hematol Educ Program 2016; 2016:1–9. DOI: https://doi.org/10.1182/asheducation-2016.1.1
7. Campello E, Spiezia L, Adamo A, Simioni P. Thrombophilia, risk factors and prevention. Expert Rev Hematol2019;12:147–58. DOI: https://doi.org/10.1080/17474086.2019.1583555
8. Saadalla A, Nandakumar V. B-093 Evaluation of the association of non-criteria antiphospholipid antibodies with the presence of lupus anticoagulant. Clin Chem 2023;69:hvad097.432. DOI: https://doi.org/10.1093/clinchem/hvad097.432
9. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306. DOI: https://doi.org/10.1111/j.1538-7836.2006.01753.x
10. Bucciarelli P, Passamonti SM, Biguzzi E, et al. Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism. J Thromb Haemost 2012;10:1783–91. DOI: https://doi.org/10.1111/j.1538-7836.2012.04858.x
11. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010;149:209–20. DOI: https://doi.org/10.1111/j.1365-2141.2009.08022.x
12. Kreidy R, Salameh P, Waked M. Lower extremity venous thrombosis in patients younger than 50 years of age. Vasc Health Risk Manag 2012;8:161-7. DOI: https://doi.org/10.2147/VHRM.S29457
13. Farmer-Boatwright MK, Roubey RAS. Venous thrombosis in the antiphospholipid syndrome. Arterioscler Thromb Vasc Biol 2009;29:321-5. DOI: https://doi.org/10.1161/ATVBAHA.108.182204
14. Riva N, Ageno W. Cerebral and splanchnic vein thrombosis: advances, challenges, and unanswered questions. J Clin Med 2020;9:743. DOI: https://doi.org/10.3390/jcm9030743
15. Mishra MN, Bedi VS. Prevalence of common thrombophilia markers and risk factors in Indian patients with primary venous thrombosis. Sao Paulo Med J 2010;128:26-7. DOI: https://doi.org/10.1590/S1516-31802010000500004
16. Ahmad N, Akhter N, Sheikh TA. Clinical and etiological profile of unprovoked thrombosis in young patients admitted at a tertiary care hospital. Int J Res Med Sci 2017;5:4595-9. DOI: https://doi.org/10.18203/2320-6012.ijrms20174603
17. Lee SY, Kim EK, Kim MS, et al. The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms. PLoS One 2017;12:e0185785. DOI: https://doi.org/10.1371/journal.pone.0185785
18. Najaf Zadeh S, Schmidli F, Jalowiec KA, et al. Prevalence and factors associated with high-risk thrombophilia: a single-center cross-sectional study of 3550 patients at a tertiary thrombosis Centre in Switzerland. Res Pract Thromb Haemost 2025;9:102864. DOI: https://doi.org/10.1016/j.rpth.2025.102864
19. Brey RL, Abbott RD, Curb JD, et al. β2-Glycoprotein 1–dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction. Stroke 2001;32:1701-6. DOI: https://doi.org/10.1161/01.STR.32.8.1701
20. Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009;8:998-1005. DOI: https://doi.org/10.1016/S1474-4422(09)70239-X
21. Chiasakul T, De Jesus E, Tong J, et al. Inherited thrombophilia and the risk of arterial ischemic stroke: a systematic review and meta-analysis. J Am Heart Assoc 2019;8:e012877. DOI: https://doi.org/10.1161/JAHA.119.012877
22. Tsalta-Mladenov M, Levkova M, Andonova S. Factor V Leiden, factor II, protein C, protein S, and antithrombin and ischemic strokes in young adults: a meta-analysis. Genes (Basel) 2022;13:2081. DOI: https://doi.org/10.3390/genes13112081
23. Makris M. Hyperhomocysteinemia and thrombosis. Clin Lab Haematol 2000;22:133-43. DOI: https://doi.org/10.1046/j.1365-2257.2000.00301.x
24. Ospina-Romero M, Cannegieter SC, den Heijer M, et al. Hyperhomocysteinemia and risk of first venous thrombosis: the influence of (unmeasured) confounding factors. Am J Epidemiol 2018;187:1392-400. DOI: https://doi.org/10.1093/aje/kwy004
25. Htut TW, Thein KZ, Oo TH. Hyperhomocysteinemia-associated thrombosis in patients with pernicious anemia. J Community Hosp Intern Med Perspect 2025;15:22–9. DOI: https://doi.org/10.55729/2000-9666.1437
26. Givens DI, Anitha S, Giromini C. Anaemia in India and its prevalence and multifactorial aetiology: a narrative review. Nutrients 2024;16:1673. DOI: https://doi.org/10.3390/nu16111673
27. Obaid M, El-Menyar A, Asim M, Al-Thani H. Prevalence and outcomes of thrombophilia in patients with acute pulmonary embolism. Vasc Health Risk Manag 2020;16:75. DOI: https://doi.org/10.2147/VHRM.S241649
28. Koopman K, Uyttenboogaart M, Vroomen PCAJ, et al. Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years. Thromb Haemost 2009;102:620–2. DOI: https://doi.org/10.1160/TH09-06-0346
29. Arachchillage DJ, Mackillop L, Chandratheva A, et al. Thrombophilia testing: A British Society for Haematology guideline. Br J Haematol 2022;198:443-58. DOI: https://doi.org/10.1111/bjh.18239
30. Laczkovics C, Grafenhofer H, Kaider A, et al. Risk of recurrence after a first venous thromboembolic event in young women. Haematologica 2007;92:1201-7. DOI: https://doi.org/10.3324/haematol.10967
31. Douketis JD, Foster GA, Crowther MA, et al . Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000;160:3431-6. DOI: https://doi.org/10.1001/archinte.160.22.3431
32. Arcelus JI, Caprini JA, Monreal M, et al. The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. J Vasc Surg 2003;38:916-22. DOI: https://doi.org/10.1016/S0741-5214(03)00789-4
CRediT authorship contribution
Monisha Harimadhavan: conceptualization; data curation; formal analysis; investigation; methodology; writing – original draft; writing – review and editing. Sharat Damodar: data curation; investigation; resources; supervision; formal analysis; writing - review and editing. Devi Prasad Shetty: resources; investigation; data curation. Bharath Ram, Shilpa Prabhu, Akshatha Nayak, Karthick R G, Nataraj K S: data curation; investigation; writing – review and editing.
Data Availability Statement
The data used to support the findings of this study are available from the corresponding author upon request.
How to Cite
1.
Harimadhavan M, Ram B, R G K, Shetty DP, Prabhu S, K S N, et al. Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years. Bleeding Thromb Vasc Biol [Internet]. 2026 Jan. 22 [cited 2026 Apr. 18];5(1). Available from: https://www.btvb.org/btvb/article/view/193
Copyright (c) 2026 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
